Estimating uncertainty of allometric biomass equations with incomplete fit error information using a pseudo-data approach: methods von Wayson, Craig A, Johnson, Kris D, Cole, Jason A, Olguín, Marcela I, Carrillo, Oswaldo I, Birdsey, Richard A

Volltext

Oxidation of arsenite by Thiomonas strains and characterization of Thiomonas arsenivorans sp. nov von Battaglia-Brunet, Fabienne, Joulian, Catherine, Garrido, Francis, Dictor, Marie-Christine, Morin, Dominique, Coupland, Kris, Barrie Johnson, D, Hallberg, Kevin B, Baranger, Philippe

Volltext

Geochemistry and microbiology of an impounded subterranean acidic water body at Mynydd Parys, Anglesey, Wales von COUPLAND, KRIS, JOHNSON, D. BARRIE

Volltext

Pilot trial of ZD1839 (IressaTM), an oral inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, in combination with carboplatin (C) and paclitaxel (P) in previously... von Laurie, S.A, Miller, V.A, Johnson, D, Ng, K.K, Heelan, R.T, Pizzo, B.A, Perez, W.J, Kris, M.G, Ochs, J, Averbuch, S

Volltext

Reduction in the incidence of chemotherapy-induced febrile neutropenia in patients with small cell lung cancer by granulocyte colony stimulating factor (r-metHuG-CSF): J. Crawford, D. Johnson, R. Stoller, I. Tabbara, M. Kris, J. Glaspy, W. Gradishar, [formula omitted], G. Lyman, A. Yahanda, R. Smith, M. Abeloff, V. Picozzi, M. Vincent, M. Stewart, and H. Ozer. St. Elizabeth's Hospital of Boston and the G-CSF study group

Volltext

Estimates of present and future flood risk in the conterminous United States von Wing, Oliver E J, Bates, Paul D, Smith, Andrew M, Sampson, Christopher C, Johnson, Kris A, Fargione, Joseph, Morefield, Philip

Volltext

Validation of a 30 m resolution flood hazard model of the conterminous United States von Wing, Oliver E. J., Bates, Paul D., Sampson, Christopher C., Smith, Andrew M., Johnson, Kris A., Erickson, Tyler A.

Volltext

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer von Herbst, Roy S, Prager, Diane, Hermann, Robert, Fehrenbacher, Lou, Johnson, Bruce E, Sandler, Alan, Kris, Mark G, Tran, Hai T, Klein, Pam, Li, Xin, Ramies, David, Johnson, David H, Miller, Vincent A

Volltext

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint von Hellmann, Matthew D, MD, Chaft, Jamie E, MD, William, William N, MD, Rusch, Valerie, Prof, Pisters, Katherine M W, Prof, Kalhor, Neda, MD, Pataer, Apar, MD, Travis, William D, Prof, Swisher, Stephen G, Prof, Kris, Mark G, Dr Prof

Volltext

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium von Guo, Robin, Berry, Lynne D., Aisner, Dara L., Sheren, Jamie, Boyle, Theresa, Bunn, Paul A., Johnson, Bruce E., Kwiatkowski, David J., Drilon, Alexander, Sholl, Lynette M., Kris, Mark G.

Volltext

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium von Pillai, Rathi N., Behera, Madhusmita, Berry, Lynne D., Rossi, Mike R., Kris, Mark G., Johnson, Bruce E., Bunn, Paul A., Ramalingam, Suresh S., Khuri, Fadlo R.

Volltext

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience von Sholl, Lynette M., Aisner, Dara L., Varella-Garcia, Marileila, Berry, Lynne D., Dias-Santagata, Dora, Wistuba, Ignacio I., Chen, Heidi, Fujimoto, Junya, Kugler, Kelly, Franklin, Wilbur A., Iafrate, A. John, Ladanyi, Marc, Kris, Mark G., Johnson, Bruce E., Bunn, Paul A., Minna, John D., Kwiatkowski, David J.

Volltext

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs von Kris, Mark G, Johnson, Bruce E, Berry, Lynne D, Kwiatkowski, David J, Iafrate, A. John, Wistuba, Ignacio I, Varella-Garcia, Marileila, Franklin, Wilbur A, Aronson, Samuel L, Su, Pei-Fang, Shyr, Yu, Camidge, D. Ross, Sequist, Lecia V, Glisson, Bonnie S, Khuri, Fadlo R, Garon, Edward B, Pao, William, Rudin, Charles, Schiller, Joan, Haura, Eric B, Socinski, Mark, Shirai, Keisuke, Chen, Heidi, Giaccone, Giuseppe, Ladanyi, Marc, Kugler, Kelly, Minna, John D, Bunn, Paul A

Volltext

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial von Chaft, Jamie E., Oezkan, Filiz, Kris, Mark G., Bunn, Paul A., Wistuba, Ignacio I., Kwiatkowski, David J., Owen, Dwight H., Tang, Yan, Johnson, Bruce E., Lee, Jay M., Lozanski, Gerard, Pietrzak, Maciej, Seweryn, Michal, Byun, Woo Yul, Schulze, Katja, Nicholas, Alan, Johnson, Ann, Grindheim, Jessica, Hilz, Stephanie, Shames, David S., Rivard, Chris, Toloza, Eric, Haura, Eric B., McNamee, Ciaran J., Patterson, G. Alexander, Waqar, Saiama N., Rusch, Valerie W., Carbone, David P.

Volltext

“Best Case/Worst Case”: Training surgeons to use a novel communication tool for high-risk acute surgical problems von Kruser, Jacqueline M., MD, Taylor, Lauren J., MD, Campbell, Toby C., MD, MSCI, Zelenski, Amy, PhD, Johnson, Sara K., MD, Nabozny, Michael J., MD, Steffens, Nicole M., MPH, Tucholka, Jennifer L., BS, Kwekkeboom, Kris L., PhD, RN, Schwarze, Margaret L., MD, MPP

Volltext

Online Network Revenue Management Using Thompson Sampling von Ferreira, Kris Johnson, Simchi-Levi, David, Wang, He

Volltext

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience von El Osta, Badi, Behera, Madhusmita, Kim, Sungjin, Berry, Lynne D., Sica, Gabriel, Pillai, Rathi N., Owonikoko, Taofeek K., Kris, Mark G., Johnson, Bruce E., Kwiatkowski, David J., Sholl, Lynette M., Aisner, Dara L., Bunn, Paul A., Khuri, Fadlo R., Ramalingam, Suresh S.

Volltext

The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2) von Aisner, Dara L, Sholl, Lynette M, Berry, Lynne D, Rossi, Michael R, Chen, Heidi, Fujimoto, Junya, Moreira, Andre L, Ramalingam, Suresh S, Villaruz, Liza C, Otterson, Gregory A, Haura, Eric, Politi, Katerina, Glisson, Bonnie, Cetnar, Jeremy, Garon, Edward B, Schiller, Joan, Waqar, Saiama N, Sequist, Lecia V, Brahmer, Julie, Shyr, Yu, Kugler, Kelly, Wistuba, Ignacio I, Johnson, Bruce E, Minna, John D, Kris, Mark G, Bunn, Paul A, Kwiatkowski, David J

Volltext

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing von Riva, Laura, Yuan, Shuofeng, Yin, Xin, Martin-Sancho, Laura, Matsunaga, Naoko, Pache, Lars, Burgstaller-Muehlbacher, Sebastian, De Jesus, Paul D., Teriete, Peter, Hull, Mitchell V., Chang, Max W., Chan, Jasper Fuk-Woo, Cao, Jianli, Poon, Vincent Kwok-Man, Herbert, Kristina M., Cheng, Kuoyuan, Nguyen, Tu-Trinh H., Rubanov, Andrey, Pu, Yuan, Nguyen, Courtney, Choi, Angela, Rathnasinghe, Raveen, Schotsaert, Michael, Miorin, Lisa, Dejosez, Marion, Zwaka, Thomas P., Sit, Ko-Yung, Martinez-Sobrido, Luis, Liu, Wen-Chun, White, Kris M., Chapman, Mackenzie E., Lendy, Emma K., Glynne, Richard J., Albrecht, Randy, Ruppin, Eytan, Mesecar, Andrew D., Johnson, Jeffrey R., Benner, Christopher, Sun, Ren, Schultz, Peter G., Su, Andrew I., García-Sastre, Adolfo, Chatterjee, Arnab K., Yuen, Kwok-Yung, Chanda, Sumit K.

Volltext

Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials von BELL, Daphne W, LYNCH, Thomas J, KREBS, Annetta D, JOHNSON, David H, GIACCONE, Gmseppe, HERBST, Roy S, MANEGOLD, Christian, FUKUOKA, Masahiro, KRIS, Mark G, BASELGA, José, OCHS, Judith S, HABER, Daniel A, HASERLAT, Sara M, HARRIS, Patricia L, OKIMOTO, Ross A, BRANNIGAN, Brian W, SGROI, Dennis C, MUIR, Beth, RIEMENSCHNEIDER, Markus J, IACONA, Renee Bailey

Volltext